NCT04264637View on ClinicalTrials.gov

Study to Find Out How Long it Takes Azelastine Hydrochloride 0.15% Nasal Spray to Relieve Symptoms in Patients Suffering From Allergic Rhinitis

PHASE3CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

February 3, 2020

Primary Completion Date

March 17, 2021

Study Completion Date

March 17, 2021

Conditions
Allergic Rhinitis
Interventions
DRUG

Azelastine hydrochloride (BAYR9258)

Single dose, metered-spray solution, 2 sprays per nostril, 205.5 mcg/spray, intranasal administration.

DRUG

Placebo

Single dose of Azelastine hydrochloride-matched placebo, metered-spray solution, 2 sprays per nostril, intranasal administration.

Trial Locations (1)

L4W 1A4

Cliantha Research, Mississauga

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT04264637 - Study to Find Out How Long it Takes Azelastine Hydrochloride 0.15% Nasal Spray to Relieve Symptoms in Patients Suffering From Allergic Rhinitis | Biotech Hunter | Biotech Hunter